I agree. Debt level is very high but I see that they realize this and are trying to address and reduce it.
Profits can't increase and E4 and others won't return $$$ quickly unless we can get the info about it out there amongst the users and script writers as quickly and as thoroughly as possible.
Potential users more than likely won't want to change what they currently use and spend their own money to try a new product out on what they may perceive as "health benefits" hearsay.
One of the more efficient (although more costly) ways to do this is to offer giveaways so people and the medical profession can freely see the game changing aspects and positive health advantages of these new products.
I have been with MYX for many, many years and the "majority voting righters" seem to like SR and keep him in and it seems not much we can do about that for now other than vote against at the annual meetings.
- Forums
- ASX - By Stock
- Ann: 2022 Half Year Investor Presentation
MYX
mayne pharma group limited
Add to My Watchlist
0.40%
!
$5.02

I agree. Debt level is very high but I see that they realize...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.02 |
Change
0.020(0.40%) |
Mkt cap ! $407.8M |
Open | High | Low | Value | Volume |
$5.05 | $5.09 | $4.96 | $774.1K | 154.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3317 | $4.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.04 | 1291 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1317 | 4.990 |
1 | 1000 | 4.980 |
1 | 1000 | 4.960 |
1 | 1291 | 4.950 |
1 | 870 | 4.940 |
Price($) | Vol. | No. |
---|---|---|
5.040 | 1291 | 1 |
5.060 | 6210 | 4 |
5.080 | 1291 | 1 |
5.090 | 1100 | 2 |
5.100 | 1875 | 2 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online